SEATTLE — Cardinal Health has created a special mobile app to help put everything attendees of its annual Retail Business Conference need to know about this year’s event in the palm of their hands — and then some.
Available for the iPhone and iPad, as well as Android and BlackBerry devices, attendees can use the app to find schedules, locate exhibitors, browse more than 50 different continuing education sessions, access Camp Cardinal Health activities for the kids, check out speaker bios, access the photo gallery, bid on the online auction, participate in surveys and much more.
For more details on Cardinal Health RBC 2013, including the complete program agenda, visit cardinalhealth.com/rbc.
And to keep up with all the news from Cardinal Health RBC 2013, visit DrugStoreNews.com/Cardinal-Health-Retail-Business-Conference-2013.
Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.
No comments found
Patients on Type 2 diabetes drugs may experience dangerously low blood sugar despite lack of disease control, study finds
OAKLAND, Calif. — Some patients with Type 2 diabetes taking drugs to lower blood sugar may experience a greater drop than is healthy for them even though their disease may not be under control, according to a new study.
The study, conducted by researchers at Kaiser Permanente and Yale University and published in the journal Diabetes Care, found that patients taking diabetes drugs experienced severe low blood sugar, or severe hypoglycemia, despite their disease not being well-controlled at the same time. According to the study, nearly 11% of the more than 9,000 study participants with Type 2 diabetes taking drugs to lower blood sugar experienced severe hypoglycemia in the prior year, regardless of their level of blood sugar control.
While low blood sugar can be treated with food or a sweet drink, severe hypoglycemia can result in dizziness, confusion, injury, coma or even death. Patients with the condition may also be at higher risk of dementia, falls, fractures and heart attacks.
"Many clinicians may assume that hypoglycemia is not much of a problem in poorly-controlled Type 2 diabetes given their high average blood-sugar levels," Kaiser Parmanente investigator and lead study author Andrew Karter said. "This study suggests that we should pay much closer attention to hypoglycemia, even in poorly-controlled patients."
PrescribeWellness, Karmadata form data-mining deal
ALISO VIEJO, Calif. — Patient communication software maker PrescribeWellness has formed a deal with data-management firm Karmadata to send targeted patient communications to pharmacy customers, the company said Tuesday.
PrescribeWellness said the goal of the deal was to improve medication adherence and health management outcomes by using Karmadata’s data mining and analysis of patient interactions for the design and automation of personalized communications. Financial terms of the deal were not disclosed.
According to research, personal communications between pharmacists and patients can form a stronger bond between the two, thus leading to higher medication adherence.
"The obstacles to adherence are different for each patient, hence it’s important to personalize communications to fit their individual needs, and that’s where big data plays a role," PrescribeWellness CEO Al Babbington said. "The Karmadata partnership allows us to affordably provide our clients the benefits of one-to-one intervention."
No comments found